Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.

Lange CM, Kutalik Z, Morikawa K, Bibert S, Cerny A, Dollenmaier G, Dufour JF, Gerlach TJ, Heim MH, Malinverni R, Müllhaupt B, Negro F, Moradpour D, Bochud PY; Swiss Hepatitis C Cohort Study Group.

Hepatology. 2012 Apr;55(4):1038-47. doi: 10.1002/hep.24787. Epub 2012 Feb 9.

PMID:
22095909
2.

Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland.

Innes HA, Hutchinson SJ, Allen S, Bhattacharyya D, Bramley P, Carman B, Delahooke TE, Dillon JF, Goldberg DJ, Kennedy N, Mills PR, Morris J, Morris J, Robertson C, Stanley AJ, Hayes P; Hepatitis C Clinical Database Monitoring Committee.

Eur J Gastroenterol Hepatol. 2012 Jun;24(6):646-55. doi: 10.1097/MEG.0b013e32835201a4. Review.

PMID:
22433796
3.

Factors associated with efficacy of pegylated interferon-α plus ribavirin for chronic hepatitis C after renal transplantation.

Li LF, Shi KQ, Lin YQ, Wang LR, He JP, Braddock M, Chen YP, Zheng MH.

Gene. 2014 Jul 10;544(2):101-6. doi: 10.1016/j.gene.2014.04.072. Epub 2014 May 1. Review.

PMID:
24793583
4.

Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3?

Jamall IS, Yusuf S, Azhar M, Jamall S.

World J Gastroenterol. 2008 Nov 21;14(43):6627-31. Review.

5.

Chronic hepatitis C virus infection.

Flamm SL.

JAMA. 2003 May 14;289(18):2413-7. Review. No abstract available.

PMID:
12746366
6.
7.

[Chronic hepatitis C: patients with mild disease].

Quer JC, Diago M, Crespo J, García-Samaniego J, Morillas R, Andrade R, Ángel Simón M.

Gastroenterol Hepatol. 2014 Jul;37 Suppl 1:3-12. doi: 10.1016/S0210-5705(15)30002-9. Review. Spanish.

PMID:
25907433
8.

Molecular mechanisms of insulin resistance in chronic hepatitis C.

Douglas MW, George J.

World J Gastroenterol. 2009 Sep 21;15(35):4356-64. Review.

9.

Pharmacogenomics of hepatitis C infections: personalizing therapy.

Booth DR, Ahlenstiel G, George J.

Genome Med. 2012 Dec 26;4(12):99. doi: 10.1186/gm400. eCollection 2012. Review.

10.

Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy.

Refaat B, Ashshi AM, El-Shemi AG, Azhar E.

Mediators Inflamm. 2015;2015:287640. doi: 10.1155/2015/287640. Epub 2015 Apr 19. Review.

Items per page

Supplemental Content

Write to the Help Desk